Stocks › CMPS
COMPASS Pathways plc
CMPS·Nasdaq·
United Kingdom·USD
United Kingdom·USD$11.56
-0.04 (-0.34%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CMPS
COMPASS Pathways plc · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CMPSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CMPS by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Shri ThanedarHouse · D · MI |
CMPSCOMPASS Pathways plc · Stock |
Sale $1,001 - $15,000 |
Feb 9, 2023 | Jan 23, 2023 | Filing ↗ |
Whale Activity
Position changes in CMPS reported for 2026-06-30 by 10 tracked institutional filers
- Increased5
- New1
- Held0
- Decreased1
- Closed0
- No prior filing3
| Filer | Shares | Value | Change |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | 4.5M | $63.3M | increased |
| Point72 Asset Management, L.P. | 2.6M | $37.1M | new |
| RENAISSANCE TECHNOLOGIES LLC | 1.4M | $20.3M | increased |
| CITADEL ADVISORS LLC | 1.0M | $14.2M | increased |
| BlackRock, Inc. | 925.4K | $13.1M | increased |
| Kalehua Capital Management LLC | 819.7K | $11.6M | — |
| MILLENNIUM MANAGEMENT LLC | 771.0K | $10.9M | decreased |
| Creek Drive Management Group LLC | 572.0K | $8.1M | — |
| D. E. Shaw & Co., Inc. | 240.9K | $3.4M | increased |
| Palo Alto Investors LP | 115.6K | $1.6M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CMPS insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
156 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Nath KabirChief Executive Officer · Director | Grant / award | +175.0K | $0.00 | $0 | Mar 26, 2026 | Form 4 ↗ |
| Loxam TeriChief Financial Officer | Grant / award | +75.0K | $0.00 | $0 | Mar 26, 2026 | Form 4 ↗ |
| Nath KabirChief Executive Officer · Director | Tax withholding | −13.1K | $6.89 | $90K | Mar 11, 2026 | Form 4 ↗ |
| Loxam TeriChief Financial Officer | Tax withholding | −1,781 | $6.89 | $12K | Mar 11, 2026 | Form 4 ↗ |
| Loxam TeriChief Financial Officer | Tax withholding | −4,467 | $7.02 | $31K | Mar 2, 2026 | Form 4 ↗ |
| Nath KabirChief Executive Officer · Director | Tax withholding | −16.2K | $6.61 | $107K | Feb 2, 2026 | Form 4 ↗ |
| Nath KabirChief Executive Officer · Director | Tax withholding | −6,366 | $4.34 | $28K | Aug 1, 2025 | Form 4 ↗ |
| Loxam TeriChief Financial Officer | Grant / award | +25.0K | $0.00 | $0 | Mar 11, 2025 | Form 4 ↗ |
| Nath KabirChief Executive Officer · Director | Grant / award | +92.0K | $0.00 | $0 | Mar 11, 2025 | Form 4 ↗ |
| Loxam TeriChief Financial Officer | Tax withholding | −4,468 | $3.67 | $16K | Mar 3, 2025 | Form 4 ↗ |
| Nath KabirChief Executive Officer · Director | Tax withholding | −15.5K | $4.31 | $67K | Feb 3, 2025 | Form 4 ↗ |
| Malievskaia Ekaterina10% owner | Sale | −776.6K | — | — | Oct 24, 2024 | Form 4 ↗ |
| Malievskaia Ekaterina10% owner | Sale | −776.6K | — | — | Oct 24, 2024 | Form 4 ↗ |
| Goldsmith George Jay10% owner | Sale | −776.6K | — | — | Oct 24, 2024 | Form 4 ↗ |
| Goldsmith George Jay10% owner | Sale | −776.6K | — | — | Oct 24, 2024 | Form 4 ↗ |
| ATAI Life Sciences AG10% owner | Sale | −2.7M | n/c | — | Sep 26, 2024 | Form 4 ↗ |
| Jenkins AnnalisaDirector | Tax withholding | −161 | $6.88 | $1K | Aug 1, 2024 | Form 4 ↗ |
| Nath KabirChief Executive Officer · Director | Tax withholding | −7,064 | $6.88 | $49K | Aug 1, 2024 | Form 4 ↗ |
| Malievskaia Ekaterina10% owner | Sale | −8,900 | $7.91 | $70K | May 21, 2024 | Form 4 ↗ |
| Malievskaia Ekaterina10% owner | Sale | −8,900 | $7.91 | $70K | May 21, 2024 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CMPS · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| ARK Genomic Revolution ETF ARK ETF Trust | 4.5M | $50.7M | 3.25% | Jul 31, 2026 |
| iShares Biotechnology ETF iShares Trust | 764.9K | $10.8M | 0.12% | Jun 30, 2026 |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 359.6K | $5.1M | 11.45% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund COLUMBIA FUNDS SERIES TRUST I | 420.9K | $3.8M | 0.17% | Apr 30, 2026 |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 178.0K | $2.5M | 1.06% | Jun 30, 2026 |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 114.3K | $1.6M | 2.09% | Jun 30, 2026 |
| ROYCE SMALL-CAP TRUST, INC. | 89.0K | $1.3M | 0.05% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 81.3K | $1.2M | 0.13% | Jun 30, 2026 |
| AdvisorShares Dorsey Wright ADR ETF AdvisorShares Trust | 61.7K | $873K | 2.09% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 60.8K | $860K | 0.02% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list CMPS's shares (CUSIP 20451W101), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming compass pathways as client
- TODD STRATEGY GROUPCOMPASS PATHWAYS INC. · 2026 Q2 · HCR$80K
Filing ↗ - AVENUE SOLUTIONSCOMPASS PATHWAYS, INC. · 2026 Q2 · HCR$30K
Filing ↗ - COMPASS PATHWAYS INC.COMPASS PATHWAYS INC. · 2026 Q2 · BUD$130K
Filing ↗ - AVENUE SOLUTIONSCOMPASS PATHWAYS, INC. · 2026 Q2 · HCR—
Filing ↗ - COMPASS PATHWAYS INC.COMPASS PATHWAYS INC. · 2026 Q1 · BUD$110K
Filing ↗
Government Contracts
Federal awards to COMPASS Pathways plc · USAspending
No federal contract awards found for COMPASS Pathways plc.
U.S. Patents
Recent USPTO applications naming COMPASS Pathways plc
No USPTO patent applications found for COMPASS Pathways plc.
Annual Financials
From CMPS's 10-K filings · XBRL
No annual XBRL figures on record for CMPS. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CMPS's price history.
Material Events (8-K)
Corporate events filed with the SEC
About COMPASS Pathways plc
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersCHESIRE, United Kingdom
IncorporatedX0
SEC CIK0001816590 ↗
Former namesCompass Rx Ltd.